544 related articles for article (PubMed ID: 27287891)
1. Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives.
Zhang RX; Wong HL; Xue HY; Eoh JY; Wu XY
J Control Release; 2016 Oct; 240():489-503. PubMed ID: 27287891
[TBL] [Abstract][Full Text] [Related]
2. Thiol redox-sensitive cationic polymers for dual delivery of drug and gene.
Syamala PS; Ramesan RM
Ther Deliv; 2018 Oct; 9(10):751-773. PubMed ID: 30277132
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs.
Huang W; Chen L; Kang L; Jin M; Sun P; Xin X; Gao Z; Bae YH
Adv Drug Deliv Rev; 2017 Jun; 115():82-97. PubMed ID: 28624478
[TBL] [Abstract][Full Text] [Related]
4. Recent progress in nanomedicine for enhanced cancer chemotherapy.
Wei G; Wang Y; Yang G; Wang Y; Ju R
Theranostics; 2021; 11(13):6370-6392. PubMed ID: 33995663
[TBL] [Abstract][Full Text] [Related]
5. Combination antitumor therapy with targeted dual-nanomedicines.
Dai W; Wang X; Song G; Liu T; He B; Zhang H; Wang X; Zhang Q
Adv Drug Deliv Rev; 2017 Jun; 115():23-45. PubMed ID: 28285944
[TBL] [Abstract][Full Text] [Related]
6. Nanocarrier-based drug combination therapy for glioblastoma.
Zhao M; van Straten D; Broekman MLD; Préat V; Schiffelers RM
Theranostics; 2020; 10(3):1355-1372. PubMed ID: 31938069
[TBL] [Abstract][Full Text] [Related]
7. Ligand-Installed Nanocarriers toward Precision Therapy.
Mi P; Cabral H; Kataoka K
Adv Mater; 2020 Apr; 32(13):e1902604. PubMed ID: 31353770
[TBL] [Abstract][Full Text] [Related]
8. Advances in Nanocarriers for Anticancer Drugs Delivery.
Ali I; Lone MN; Suhail M; Mukhtar SD; Asnin L
Curr Med Chem; 2016; 23(20):2159-87. PubMed ID: 27048343
[TBL] [Abstract][Full Text] [Related]
9. Nanocarriers as an emerging platform for cancer therapy.
Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.
Li J; Wang Y; Zhu Y; Oupický D
J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-assisted combination therapies for effective cancer treatment.
Hu CM; Aryal S; Zhang L
Ther Deliv; 2010 Aug; 1(2):323-34. PubMed ID: 22816135
[TBL] [Abstract][Full Text] [Related]
13. Ligand decorated biodegradable nanomedicine in the treatment of cancer.
Ahmad E; Ali A; Fatima MT; Nimisha ; Apurva ; Kumar A; Sumi MP; Sattar RSA; Mahajan B; Saluja SS
Pharmacol Res; 2021 May; 167():105544. PubMed ID: 33722711
[TBL] [Abstract][Full Text] [Related]
14. Can nanomedicines kill cancer stem cells?
Zhao Y; Alakhova DY; Kabanov AV
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1763-83. PubMed ID: 24120657
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-Based Combination Therapy for Cancer Treatment.
Yhee JY; Son S; Lee H; Kim K
Curr Pharm Des; 2015; 21(22):3158-66. PubMed ID: 26027570
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine: the promise and challenges in cancer chemotherapy.
Naguib YW; Cui Z
Adv Exp Med Biol; 2014; 811():207-33. PubMed ID: 24683034
[No Abstract] [Full Text] [Related]
17. Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives.
Cadete A; Alonso MJ
Nanomedicine (Lond); 2016 Sep; 11(17):2341-57. PubMed ID: 27526874
[TBL] [Abstract][Full Text] [Related]
18. DNA origami applications in cancer therapy.
Udomprasert A; Kangsamaksin T
Cancer Sci; 2017 Aug; 108(8):1535-1543. PubMed ID: 28574639
[TBL] [Abstract][Full Text] [Related]
19. Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications.
Chakraborty S; Dhakshinamurthy GS; Misra SK
J Biomed Mater Res A; 2017 Oct; 105(10):2906-2928. PubMed ID: 28643475
[TBL] [Abstract][Full Text] [Related]
20. Polymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancer.
Yang Q; Yang Y; Li L; Sun W; Zhu X; Huang Y
ACS Appl Mater Interfaces; 2015 Apr; 7(12):6661-73. PubMed ID: 25775367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]